Winhycare Pharma · Research use only
Peptides studied in preclinical tissue-repair research. Neither is approved as a medicine; both are supplied strictly for laboratory research use.
CAS 137525-51-0 · 1419.56 g/mol · also supplied as API
pentadecapeptide (body-protection compound). Not approved by the FDA, EMA or any other drug regulatory agency for therapeutic use. Handled only as a research / reference-standard material. In 2023 the US FDA placed BPC-157 in Category 2 of its interim compounding bulk-substances policy, citing immunogenicity and impurity concerns; it has no USP/NF monograph and no marketing authorisation.
CAS 77591-33-4 · 4963.44 g/mol
synthetic thymosin beta-4 fragment. Not approved by the FDA, EMA or other major regulators for any therapeutic use. It is handled only as a research / reference-standard material. Thymosin beta-4 / TB-500 is also prohibited at all times in sport under the World Anti-Doping Agency (WADA) Prohibited List (class S2).
| Peptide | CAS | Molecular weight | Sequence | Purity |
|---|---|---|---|---|
| BPC-157 | 137525-51-0 | 1419.56 g/mol | 15 amino acids (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val) | >99% |
| TB-500 (Thymosin Beta-4) | 77591-33-4 | 4963.44 g/mol | 43 amino acids (N-terminally acetylated) | >99% |
Research use only. Research use only. Not for human or veterinary use, and not for use in food, drugs, medical devices or cosmetics. Buyers are responsible for complying with the import and use regulations of their country.
BPC-157, TB-500 (Thymosin Beta-4), each at >99% purity for research use only.
No. They are supplied for laboratory research use only and are not for human or veterinary use. We do not provide dosing or usage advice.
Material is supplied with QC documentation. Tell us in your enquiry what your lab or quality team needs.
Yes. Include the quantity in your enquiry; bulk and distributor quantities are quoted on request.
Products & services
Guides
